The introduction of a generic version of sanofi-aventis' Ambien [zolpidem] will enable "multi-million dollar savings"

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 528, 2007-05-19 , pp. 10-10(1)

Keywords: Adolescents; Children; Cost-minimisation; Drug-utilisation; Generic-substitution; Healthcare-news; Insomnia, treatment; Medco-Health-Solutions; Zolpidem, therapeutic use

Document Type: Short communication

Links for this article

http://www.ingentaconnect.com/adis/peon/2007/00000001/00000528/art00026
http://openurl.ingenta.com/content?genre=article&issn=1173-5503&volume=1&issue=528&spage=10&epage=10